Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Saskatchewan

$17,500.00

Role of DDX41 in P-bodies Assembly and its Connection to MDS/AML

EF 2022-23

Résumé
Myelodysplastic syndrome (MDS) is characterized by unusual cells within the bone marrow that causes issues making healthy blood cells, producing unuseful cells. About 30% of MS+DS patients will progress to acute myeloid leukemia (AML), an aggressive blood cancer, when the amount of unusual white blood cells in the bone marrow becomes too much. Mutations in the DEAD-box helicase 41 (DDX41) genes are associated with MDS/AML. The missense mutation, a base pair change that changes the amino acid produced, in R525H is found in over 70% of patients. However, the molecular pathogenesis remains unknown. Processing bodies (P-bodies) are cytoplasmic protein complexes involved in degradation and translational arrest of mRNA. The aberrant assembly or disassembly of P-bodies has pathological implications initiation and progression of MDS/AML. Recently we found that DDX41 is required for P-bodies formation. This leads to our hypothesis: DDX41 regulates P-bodies formation, mutation in DDX41 dysregulate P-bodies formation, and ultimately cause MDS/AML. The objective of this project is to discover roles of DDX41 in P-bodies assembly, and to understand the effects of MDS/AML patient mutation R525H. We will use qPCR, Western Blot, and confocal microscope to examine the expression and cellular localization of gene/protein EDC4, 4E-T, and LSM14A, three core components of P-bodies, in DDX41 knockout cells (compared to wild type). To understand the impact of R525H mutation, we will over express R525H in DDX41 deficient cells and examine whether it can rescue P-bodies assembly. In conclusion, this study will uncover novel mechanisms of DDX41 in P-bodes formation, and the molecular pathogenesis of DDX41 related MDS/AML, which might lead to novel drug targets for the treatments of MDS/AML.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486063
Name
Winstone Lacey A
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of DDX41 in P-bodies Assembly and its Connection to MDS/AML
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Myeloid Leukaemia (Aml); Biochemistry; Cancer; Ddx41; Helicase; Leukaemia; Myelodysplastic Syndrome (Mds); P-Bodies
Abstract
Myelodysplastic syndrome (MDS) is characterized by unusual cells within the bone marrow that causes issues making healthy blood cells, producing unuseful cells. About 30% of MS+DS patients will progress to acute myeloid leukemia (AML), an aggressive blood cancer, when the amount of unusual white blood cells in the bone marrow becomes too much. Mutations in the DEAD-box helicase 41 (DDX41) genes are associated with MDS/AML. The missense mutation, a base pair change that changes the amino acid produced, in R525H is found in over 70% of patients. However, the molecular pathogenesis remains unknown. Processing bodies (P-bodies) are cytoplasmic protein complexes involved in degradation and translational arrest of mRNA. The aberrant assembly or disassembly of P-bodies has pathological implications initiation and progression of MDS/AML. Recently we found that DDX41 is required for P-bodies formation. This leads to our hypothesis: DDX41 regulates P-bodies formation, mutation in DDX41 dysregulate P-bodies formation, and ultimately cause MDS/AML. The objective of this project is to discover roles of DDX41 in P-bodies assembly, and to understand the effects of MDS/AML patient mutation R525H. We will use qPCR, Western Blot, and confocal microscope to examine the expression and cellular localization of gene/protein EDC4, 4E-T, and LSM14A, three core components of P-bodies, in DDX41 knockout cells (compared to wild type). To understand the impact of R525H mutation, we will over express R525H in DDX41 deficient cells and examine whether it can rescue P-bodies assembly. In conclusion, this study will uncover novel mechanisms of DDX41 in P-bodes formation, and the molecular pathogenesis of DDX41 related MDS/AML, which might lead to novel drug targets for the treatments of MDS/AML.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Winstone, Lacey A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~